info@biomedres.us   +1 (720) 414-3554
  One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA

Biomedical Journal of Scientific & Technical Research

May, 2021, Volume 35, 5, pp 28021-28022

Opinion

Opinion

What Should We Do to Break Clinical Inertia in T2DM?

Takashi Ohoshi1* and Kishio Nanjo2

Author Affiliations

1Department of Clinical Examination, Wakayama Rosai Hospital, Japan

2Department of Internal Medicine, Wakayama Rosai Hospital, Japan

Received: May 07, 2021 | Published: May 17, 2021

Corresponding author: Takashi Ohoshi, Department of Clinical Examination, Wakayama Rosai Hospital, Japan

DOI: 10.26717/BJSTR.2021.35.005765

Abstract

Keywords: T2DM; Clinical Inertia; Opened Medical Team; Patient-centered Care

Opinion

T2DM is a common disease progressed over the long duration of life. Because of lacking apparent symptoms and signs in many cases, interrelationship between patient and doctor becomes complicated.

Process for Adjusting Blood Glucose

Both a patient and his(her) doctor cannot know his(her) disease state before blood A1C level is shown. His(her) prescription is determined by the A1C level at visit and evaluated by the A1C level of next visit. If patient reaches target A1C level determined by clinical guideline and has no hypoglycemic symptoms and signs, his(her) prescription is proposed to continue, and if not, is proposed to adjust. This process is repeated continuously unless patient disrupts to visit for any reason.

Origin of Clinical Inertia

If patient disagrees proposal for his(her) lifestyle or adjustment of oral blood-glucose lowering drugs, GLP1 analogues, or insulin derivatives, his(her) doctor will try either to recommend it, or to propose other choice. Negotiation begins between patient and his(her) doctor, and then his(her) prescription is determined. If next visit A1C level is not reached to target level, present prescription should be adjusted. But many patients do not like the change of prescription, especially when they want it by themselves. And the same prescription will be continued. From this time, clinical inertia [1] arises.

What Should We Do?

It is not impossible, but difficult, to break clinical inertia in the closed relationship between patient and his(her) doctor. Therefore, we should do organize medical team, which consists of patient him(her)self, his(her) doctor (general practitioner, diabetologist, if necessary, cardiologist, ophthalmologist, neurologist, nephrologist, dermatologist, orthopedic surgeon, etc.), diabetes educator (nurse practitioner, dietitian, pharmacist, physical therapist, and laboratory technician), other co-worker (clerk, medical social worker, care worker, public health nurse, etc.), and further his(her) family member(s). Opened relationship (Figure1) formed within this team would break clinical inertia.

Patient-Centered Care

If harmonized relationship, as had Steno-2 Study [2] shown, has developed, the medical team could provide patient-centered care [3] in T2DM.

Figure 1: Opened Medical Team: Nurse practitioner, dietitian, pharmacist, physical therapist, and laboratory technician belong to diabetes educator.

References

Opinion

What Should We Do to Break Clinical Inertia in T2DM?

Takashi Ohoshi1* and Kishio Nanjo2

Author Affiliations

1Department of Clinical Examination, Wakayama Rosai Hospital, Japan

2Department of Internal Medicine, Wakayama Rosai Hospital, Japan

Received: May 07, 2021 | Published: May 17, 2021

Corresponding author: Takashi Ohoshi, Department of Clinical Examination, Wakayama Rosai Hospital, Japan

DOI: 10.26717/BJSTR.2021.35.005765

Abstract

Keywords: T2DM; Clinical Inertia; Opened Medical Team; Patient-centered Care